Spirometry in the prophylaxis of respiratory system diseases – a retrospective study
More details
Hide details
Department of Pulmonology, Faculty of Public Health, University of Warmia and Mazury in Olsztyn, Poland
Warmian-Masurian Cancer Center of the Ministry of the Interior and Administration’s Hospital, Olsztyn, Poland
Anna Romaszko-Wojtowicz   

Department of Pulmonology, Faculty of Public Health, Collegium Medicum,University of Warmia and Mazury in Olsztyn, Jagiellońska 78, 10-357 Olsztyn, Poland
Submission date: 2021-05-31
Final revision date: 2021-07-21
Acceptance date: 2021-07-21
Online publication date: 2021-09-24
Pol. Ann. Med. 2021;28(2):187–193
Diseases of the respiratory system are the third cause of mortality worldwide in terms of incidence. A spirometry test enables early detection of changes in the respiratory tract of persons with minor ailments, as well as the diagnosis of a fairly advanced illness whose symptoms have been neglected by the patient.

The aim of this study has been to identify any irregularities in spirometry tests in the population of the province of Warmia and Mazury.

Material and methods:
The study covered 1061 persons living in the province of Warmia and Mazury, of which 637 patients (188 women and 249 men) were included in the analysis. The participants provided their basic demographic and medical data through a survey. Each participant underwent a spirometry test according to the European Respiratory Society and American Thoracic Society 2005 guidelines. Statistical analysis was carried out in a Statistica software package.

Results and Discussion:
The study showed that women smoke significantly less than men – the average pack years for women and men were 4.02 (SD 9.33) and 8.11 (SD 17.19) (P < 0.001), respectively. A higher number of pack years contributed to a higher incidence of the respiratory tract symptoms (cough, wheeze, breathlessness) (P < 0.05). Compared to men, women were more often observed to suffer from grade 1 or 2 degree dyspnoea on the mMRC scale.

Pulmonary function tests play an important role in the diagnosis of respiratory system diseases. Promotion of prophylactic measures in streets of cities helps to improve patients’ awareness of the condition of their health.

Clatici VG, Voicu C, Voaides C, Roseanu A, Icriverzi M, Jurcoane S. Diseases of civilization – Cancer, diabetes, obesity and acne – the implication of milk, IGF-1 and mTORC1. Maedica (Bucur). 2018;13(4):273–281.
Forum of International Respiratory Societies. The Global Impact of Respiratory Disease. Second Edition. Sheffield: European Respiratory Society; 2017. Accessed: 17.09.2021.
Central Statistical Office. Demographic situation of the Warmian-Masurian Voivodeship in 2019 r. [in Polish] Accessed: 22.05.2021.
Neopane A, Poudel M, Pradhan B, Regmi S, Karki DB. Spirometry in evaluation of respiratory diseases. J Nepal Med Assoc. 2006;45(164):332–336.
Renzetti AD. Standardization of spirometry. Am Rev Respir Dis. 1979;119(5):693–694.
Standardization of spirometry – 1987 update. Statement of the American Thoracic Society. Am Rev Respir Dis. 1987;136(5):1285–1298.
Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med. 1995;152(3):1107–1136.
Quanjer PH. Standardized lung function testing. Bull Eur Physiopathol Respir. 1983;19 (Suppl 5):1–95.
Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl. 1993;16:5–40.
Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338.
Sharafkhaneh A, Hanania NA, Kim V. Pathogenesis of emphysema: from the bench to the bedside. Proc Am Thorac Soc. 2008;5(4):475–477.
Saetta M, Turato G, Maestrelli P, Mapp CE, Fabbri LM. Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;163(6):1304–1309.
Śliwiński P, Górecka D, Jassem E, Pierzchała W. Polish Respiratory Society Guidelines for Chronic Obstructive Pulmonary Disease. Pneumonol Alergol Pol. 2014;82(3):227–263.
Vollmer WM, Gíslason T, Burney P, et al. Comparison of spirometry criteria for the diagnosis of COPD: Results from the BOLD study. Eur Respir J. 2009;34(3):588–597.
Mehrparvar AH, Sakhvidi MJZ, Mostaghaci M, Davari MH, Hashemi SH, Zare Z. Spirometry values for detecting a restrictive pattern in occupational health settings. Tanaffos. 2014;13(2):27–34.
Venkateshiah SB, Ioachimescu OC, McCarthy K, Stoller JK. The utility of spirometry in diagnosing pulmonary restriction. Lung. 2008;186(1):19–25.
Najafzadeh M, Marra CA, Lynd LD, et al. Future impact of various interventions on the burden of COPD in Canada: A dynamic population model. PLoS One. 2012;7(10):e46746.
Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med. 2002;162(20):2269–2276.
Fukuchi Y. The aging lung and chronic obstructive pulmonary disease: similarity and difference. Proc Am Thorac Soc. 2009;6(7):570–572.
Sharma G, Goodwin J. Effect of aging on respiratory system physiology and immunology. Clin Interv Aging. 2006;1(3):253–260.
Braman SS, Skloot GS. Pulmonary Disease in the Aging Patient, An Issue of Clinics in Geriatric Medicine. Philadelphia (Pa): Elsevier Health Sciences; 2017.
Nie JX, Wang L, Upshur RE. Mortality of elderly patients in Ontario after hospital admission for chronic obstructive pulmonary disease. Can Respir J. 2007;14(8):485–489.
Pb S, M FA, O LJ, et al. Alpha-1 antitrypsin deficiency in COPD patients: A cross-sectional study. Arch Bronconeumol. 2015;51(11):539–543.
Liu Y, Pleasants RA, Croft JB, et al. Smoking duration, respiratory symptoms, and COPD in adults aged ≥45 years with a smoking history. Int J Chron Obstruct Pulmon Dis. 2015;10:1409–1416.
Stein L, Urban MI, Weber M, et al. Effects of tobacco smoking on cancer and cardiovascular disease in urban black South Africans. Br J Cancer. 2008;6;98(9):1586–1592.
Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370(9589):765–773.
Barnes PJ. Sex differences in chronic obstructive pulmonary disease mechanisms. Am J Respir Crit Care Med. 2016;193(8):813–814.
Kamal R, Srivastava AK, Kesavachandran CN. Meta-analysis approach to study the prevalence of chronic obstructive pulmonary disease among current, former and non-smokers. Toxicol Rep. 2015;2:1064–1074.
Arcavi L, Benowitz NL. Cigarette smoking and infection. Arch Intern Med. 2004;164(20):2206–2216.
Rennard SI, Vestbo J. COPD: the dangerous underestimate of 15%. Lancet. 2006;367(9518):1216–1219.
Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS; GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001;163(5):1256–1276.
Lundbäck B, Lindberg A, Lindström M, et al. Not 15 but 50% of smokers develop COPD? – Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med. 2003;97(2):115–122.
Menezes AMB, Perez-Padilla R, Jardim JRB, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet. 2005;366(9500):1875–1881.
Global Initiative for Chronic Obstructive Lung Disease. 2020 Gold Reports. Accessed: 22.05.2021.
Olszewska J. Rehabilitation for chronic obstructive pulmonary disease patients. Pol Ann Med. 2011;18(1):177–187.
Koo H-K, Park S-W, Park J-W, et al. Chronic cough as a novel phenotype of chronic obstructive pulmonary disease. COPD. 2018;13:1793–1801.
Jatakanon A, Lalloo U, Lim S, Chung KF, Barnes P. Increased neutrophils and cytokines, TNF-α and IL-8, in induced sputum of non-asthmatic patients with chronic dry cough. Thorax. 1999;54(3):234–237.
Niimi A, Torrego A, Nicholson AG, Cosio BG, Oates TB, Chung KF. Nature of airway inflammation and remodeling in chronic cough. J Allergy Clin Immunol. 2005;116(3):565–570.
Müllerová H, Lu C, Li H, Tabberer M. Prevalence and burden of breathlessness in patients with chronic obstructive pulmonary disease managed in primary care. PLoS One. 2014;9(1):e85540.
Pumar MI, Gray CR, Walsh JR, Yang IA, Rolls TA, Ward DL. Anxiety and depression-Important psychological comorbidities of COPD. J Thorac Dis. 2014;6(11):1615–1631.